School-based HPV Vaccination: The Challenges in a Brazilian Initiative
Authors:
- Julio Cesar TeixeiraJTJulio Cesar Teixeira
- Mariana Silva Castro ViannaMVMariana Silva Castro Vianna
- Diama Bhadra ValeDVDiama Bhadra Vale
- Daniella Moretti ArboreDADaniella Moretti Arbore
- Thais Helena Wilmers PeriniTPThais Helena Wilmers Perini
- Tulio Jose Tomass CoutoTCTulio Jose Tomass Couto
- Jose Pedroso NetoJNJose Pedroso Neto
- Luiz Carlos ZeferinoLZLuiz Carlos Zeferino
Open Access
- 21 December 2021
- journal article
- research article
- Published by Federação das Associações de Ginecologia e Obstetrícia in Revista Brasileira de Ginecologia e Obstetrícia
- Vol. 43 (12) , 926-931
Abstract
Objective The present study assesses the implementation and the impact after 2 years of a school-based human papillomavirus (HPV) vaccination program in a Brazilian city. Methods A prospective study assessing the implementation of the program, offering quadrivalent HPV vaccine in two annual doses to girls and boys aged from 9 to 10 years old. The program was started in the city of Indaiatuba, state of São Paulo, Brazil, in 2018, and had authorization from the National Immunization Program. The number of HPV vaccine first doses applied and the coverage in 2018 was calculated and compared to the year 2017. There were described events that have influenced the results. Results The program invited 4,878 children through schools (87.1% of the target population), and 7.5% refused vaccination. Several concurrent events required or competed for health professionals of the vaccination teams. The coverage of the first dose (between 9 and 10 years old) was 16.1% in 2017 and increased to 50.5% in 2018 (p < 0.0001). The first dose in all ages increased 78% in 2018 compared with 2017 (6,636/3,733). Competing demands over the program continued in 2019, and the first dose coverage dropped (26.9%). For 2020, a municipal law instituted school-based vaccination and the creation of dedicated teams for vaccination, and these strategies are waiting to be tested. Conclusion School-based annual HPV vaccination in children between 9 and 10 years old was feasible and increased vaccination coverage, regardless of gender, although the program was vulnerable to competing events.Keywords
This publication has 12 references indexed in Scilit:
- Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization PracticesMMWR. Morbidity and Mortality Weekly Report, 2019
- The projected timeframe until cervical cancer elimination in Australia: a modelling studyThe Lancet Public Health, 2019
- Achieving high uptake of human papillomavirus vaccination in Malaysia through school-based vaccination programmeBMC Public Health, 2018
- The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent?Eurosurveillance, 2018
- Potential impact of introducing a nonavalent HPV vaccinationInternational Journal of Gynecology & Obstetrics, 2018
- Use of a 2-Dose Schedule for Human Papillomavirus Vaccination — Updated Recommendations of the Advisory Committee on Immunization PracticesMMWR. Morbidity and Mortality Weekly Report, 2016
- Início da vida sexual entre adolescentes (10 a 14 anos) e comportamentos em saúdeRevista Brasileira de Epidemiologia, 2015
- Immunogenicity of 2 Doses of HPV Vaccine in Younger Adolescents vs 3 Doses in Young WomenJAMA, 2013
- Saúde sexual dos adolescentes segundo a Pesquisa Nacional de Saúde dos EscolaresRevista Brasileira de Epidemiologia, 2011
- Human papillomavirus vaccines. WHO position paper.2009